Description

Pyrazinecarboxamide, n-[4-[(Hexahydro-1H-Azepin-1-Yl)Sulfonyl]Phenyl]-5-Methyl- (9Ci) is a high-purity, advanced pharmaceutical intermediate characterized by its complex heterocyclic structure incorporating pyrazine and azepine moieties. This compound is of significant value in modern organic synthesis, serving as a critical building block for the development of novel active pharmaceutical ingredients (APIs). It is primarily required by research institutions and pharmaceutical manufacturers engaged in the discovery and production of new therapeutic agents, particularly in areas requiring sophisticated molecular scaffolds.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, especially for central nervous system (CNS) and metabolic disorder targets.
• Agrochemical Research: Used in the development of new-generation herbicides and fungicides, leveraging its unique heterocyclic core.
• Material Science: Serves as a monomer or additive in the research of specialty polymers and advanced organic electronic materials.
• Chemical Biology Probe: Utilized in academic and industrial research as a molecular tool for studying enzyme inhibition and receptor binding.
• Custom Synthesis & Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for client-specific synthetic routes.

Basic Information

Product Name	Pyrazinecarboxamide, n-[4-[(Hexahydro-1H-Azepin-1-Yl)Sulfonyl]Phenyl]-5-Methyl- (9Ci)
CAS No.	603945-78-4
Molecular Formula	C19H26N4O3S
Molecular Weight	390.50 g/mol
Synonyms	N-[4-(Hexahydro-1H-azepin-1-ylsulfonyl)phenyl]-5-methylpyrazine-2-carboxamide; 5-Methyl-N-[4-[(hexahydro-1H-azepin-1-yl)sulfonyl]phenyl]pyrazine-2-carboxamide; 603945-78-4; UNII-9K4F8V3W4S; 9K4F8V3W4S; SCHEMBL218062; AKOS040759623; ZINC000003869756
EINECS	Contact for details

Quality Control

Our Pyrazinecarboxamide intermediate is manufactured under strict quality management systems. Every batch undergoes comprehensive analytical testing, including HPLC for purity, NMR and MS for structural confirmation, and stringent control of residual solvents and impurities. A detailed Certificate of Analysis (COA) is provided with each shipment, ensuring full traceability and compliance with cGMP guidelines where applicable for pharmaceutical development.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider inert atmosphere conditions to ensure maximum stability.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any single impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.